Critical Overview on Endocrine Disruptors in Diabetes Mellitus
Charlotte Hinault(Inserm), Nicolas Chevalier(Inserm), Philippe Caroli-Bosc(Inserm), Frédéric Bost(Inserm)
Cited by 48
Related Papers
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
|Oncogene|2008|852
Human Health and Ocean Pollution
|Annals of Global Health|2020|751
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
|Cancer Research|2011|620
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
|Cancer Research|2010|528
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
|Molecular Cancer Therapeutics|2010|490